Skip to content
OpenCapital
Get started

Core Laboratories CLB Tax receivable within other current assets

Tax receivable within other current assets at other companies

RPC logo
RPCRES
——
Patterson-UTI Energy logo
Patterson-UTI EnergyPTEN
——

Other financials

Income statement

See full
Revenue$121.8M-1.4%
Operating income$1.9M-57.3%
Net income-$789.0K-412%
EPS (diluted)-$0.02—

Balance sheet

See full
Cash & equivalents$22.8M+3.2%
Total debt$167.8M-6.8%
Total equity$268.9M+6.1%
Total assets$587.7M+0.3%

Cash flow

See full
Operating cash flow$4.0M-40.5%
CapEx$3.4M+23.8%
Free cash flow$517.0K-86.7%

Valuation

See full
Market cap$492.77M-9.3%
Enterprise value$637.8M-7.6%
P/E17×-1.4×
P/S0.9×-0.1×

Profitability

See full
Operating margin10.3%-0.2pp
Net margin5.5%+0.1pp
FCF margin4.3%-4.6pp

Returns & leverage

See full
Return on equity11.1%-0.4pp
Debt / equity0.6×-0.1×
Current ratio2×-0.2×

Where this comes from

Reported directly by Core Laboratories in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesReceivable.

The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Core Laboratories's tax receivable within other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Core Laboratories's tax receivable within other current assets?
Core Laboratories (CLB) reported tax receivable within other current assets of $6.92M in Q1 2026.
How has Core Laboratories's tax receivable within other current assets changed year-over-year?
Core Laboratories's tax receivable within other current assets decreased by 50.4% year-over-year, from $13.96M to $6.92M.
What is the long-term trend for Core Laboratories's tax receivable within other current assets?
Over 3 years (2022 to 2025), Core Laboratories's tax receivable within other current assets has grown at a -3.9% compound annual growth rate (CAGR), from $8.19M to $7.27M.